Publications by authors named "Nina Mufti"

Claim this Profile
E
Effects of an amustaline (S-303)/glutathione pathogen reduction system on the in vitro quality of plasma and platelets in treated whole blood.
M Reza Khoshi, Ayantu Jinfessa, Anais Pongerard, Michelle Gatmaitan, Melanie Sweeney, Nina Mufti

Transfusion· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amustaline/glutathione pathogen-reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trial.
Ian J Welsby, Michael E Sekela, Edward L Snyder, James D Gorham, John S McNeil, Nina Mufti

Transfusion· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing hepatitis B virus infectivity in blood components following pathogen reduction using a human hepatocyte model.
Bryan J Visser, Santanu Biswas, Rana Eltahan, Rafaelle Fares-Gusmao, Subramanian Yegneswaran, Nina Mufti

Transfusion· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel acridine flow cytometry marker to track post-transfusion amustaline/glutathione pathogen-reduced red blood cell survival in sickle cell disease patients.
Richard J Benjamin, John P Pitman, Christopher Karim, Shengnan Huang, Anna Erickson, Nina Mufti

Transfusion· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human leukocyte antigen alloimmunization in a randomized trial of amustaline/glutathione pathogen-reduced red cells in complex cardiac surgery patients.
Philip J Norris, Mars Stone, Clara Di Germanio, Brendan Balasko, Zhanna Kaidarova, Nina Mufti

Transfusion· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing the antibody response to amustaline/glutathione pathogen-reduced red blood cells.
Christopher Karim, Anil Panigrahi, Ronald G Pearl, Neel R Sodha, Thomas M Beaver, Nina Mufti

Transfusion· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo genotoxicity assessment of N-(-9 acridinyl)-b-alanine hydrochloride (S-300) using a validated Pig-a mutagenesis assay.
Anne North, Katherine Ling, Guillaume Ricaud, Leon F Stankowski, Jennifer A Daly, Nina Mufti

Transfusion· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trial.
Edward L Snyder, Michael E Sekela, Ian J Welsby, Yoshiya Toyoda, Mohamed Alsammak, Nina Mufti

Trials· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage.
Jose A Cancelas, Jamie R Genthe, Moritz Stolla, Neeta Rugg, S Lawrence Bailey, Nina Mufti

Transfusion· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of natural and acquired antibodies to amustaline/glutathione pathogen reduced red blood cells.
Christof Geisen, Anne North, Lisa Becker, Veronika Brixner, Melissa von Goetz, Nina Mufti

Transfusion· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathione.
Anne K North, Nina Mufti, Theresa Sullivan, Laurence Corash

Transfusion· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemia.
Yesim Aydinok, Antonio Piga, Raffaella Origa, Nina Mufti, Anna Erickson

Br J Haematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgery.
Veronika Brixner, Arndt-Holger Kiessling, Katharina Madlener, Markus M Müller, Johannes Leibacher, Nina Mufti

Transfusion· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma treated with amotosalen and ultraviolet A light retains activity for hemostasis after 5 days post-thaw storage at 1 to 6 C.
Anna Erickson, Katie Waldhaus, Tovo David, Norman Huang, Salvador Rico, Nina Mufti

Transfusion· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Red blood cell in vitro quality and function is maintained after S-303 pathogen inactivation treatment.
Kelly M Winter, Lacey Johnson, Matthew Kwok, Diana Vidovic, Ryan A Hyland, Nina Mufti

Transfusion· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process.
Jose A Cancelas, Larry J Dumont, Neeta Rugg, Zbigniew M Szczepiorkowski, Louis Herschel, Nina A Mufti

Transfusion· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical pharmacokinetic and toxicology assessment of red blood cells prepared with S-303 pathogen inactivation treatment.
Anne North, Vic Ciaravino, Nina Mufti, Laurence Corash

Transfusion· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates.
Reinhard Henschler, Erhard Seifried, Nina Mufti

Transfus Med Hemother· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis